Surmodics Announces TRANSCEND Trial 36-Month Data to be Presented at 50th Annual VEITH Symposium

Dr. Peter A. Schneider to share trial results during a Nov. 15 session

...

Related Keywords

San Francisco ,California ,United States ,Minnesota ,Eden Prairie ,New York ,Kenneth Rosenfield ,Dcbs Medtronic ,Petera Schneider ,Surmodics Inc ,Nasdaq ,Trial Steering Committee ,Transcend ,Professor Of Surgery At University California ,Steering Committee ,Year Results ,With In Pact ,For Treating Fempop Lesions ,New Developments ,Drug Coated Balloons ,Drug Eluting Stents ,Randomized Controlled Trials ,Leipzig Interventional Course ,Vascular Interventional Advances ,European Union ,Forward Looking Statements ,Annual Report ,Markets ,